GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
27 hedge funds and large institutions have $17.2M invested in Aevi Genomic Medicine Inc in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
27
Holding in Top 10
–
Calls
$789K
Puts
–
Top Buyers
| 1 | +$148K | |
| 2 | +$137K | |
| 3 | +$41.9K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$23.3K |
| 5 |
VanEck Associates
New York
|
+$18.4K |
Top Sellers
| 1 | -$318K | |
| 2 | -$148K | |
| 3 | -$48.1K | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$21.4K |
| 5 |
KCPG
Kavar Capital Partners Group
Leawood,
Kansas
|
-$13K |